Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms

Transplantation of whole bone marrow (BMT) as well as ex vivo–expanded mesenchymal stromal cells (MSCs) leads to striking clinical benefits in children with osteogenesis imperfecta (OI); however, the underlying mechanism of these cell therapies has not been elucidated. Here, we show that non–(plasti...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Otsuru, Satoru, Gordon, Patricia L., Shimono, Kengo, Jethva, Reena, Marino, Roberta, Phillips, Charlotte L., Hofmann, Ted J., Veronesi, Elena, Dominici, Massimo, Iwamoto, Masahiro, Horwitz, Edwin M.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2012
Teme:
Transplantation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433095/
https://ncbi.nlm.nih.gov/pubmed/22829629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-12-400085
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items